Current Management of Polycystic Ovary Syndrome

1. Overview and defiitions of polycystic ovary syndrome and the polycystic ovary
2. Genetics and pathogenesis of polycystic ovary syndrome
3. Ethnic variations in the expression of polycystic ovary syndrome
4. Quality of life for women with polycystic ovary syndrome
5. Insulin resistance, the metabolic syndrome and polycystic ovary syndrome
6. Management of polycystic ovary syndrome through puberty and adolescence
7. Long-term health risks of polycystic ovary syndrome
8. Approaches to lifestyle management in polycystic ovary syndrome
9. Management of obesity in polycystic ovary syndrome, including anti-obesity drugs and bariatric surgery
10. Defiition of hyperandrogenism
11. Treatment of hyperandrogenism in polycystic ovary syndrome
12. Choices in the treatment of anovulatory polycystic ovary syndrome
13. Predictors of ovarian response to ovarian stimulation: progress towards individualised treatment in ovulation induction
14. Surgical management of anovulatory infertility in polycystic ovary syndrome
15. The role of insulin-sensitising drugs in the treatment of polycystic ovary syndrome
16. The role of in vitro maturation of oocytes for anovulatory polycystic ovary syndrome
17. Acupuncture and/or herbal therapy as an alternative or complement for relief of polycystic ovary syndrome-related symptoms
18. Consensus views arising from the 59th Study Group: Current Management of Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) is the most common endocrine disturbance, affecting 10-15% of women in the UK. The definition of PCOS has been much debated, while its pathophysiology appears to be multifactorial and is still being actively researched. There is no doubt that PCOS has a significant effect on quality of life and psychological morbidity and, as many specialists are involved in its management, a multidisciplinary approach is required. The 59th RCOG Study Group brought together a range of experts who treat women with PCOS. This book presents the findings of the Study Group, including: • a definition of PCOS • the accuracy of diagnostic interventions • the particular challenges of adolescent diagnosis and management • the correlation to ethnicity • current approaches to therapy • the potential individualisation of therapy • the role of the alternative therapies used to manage some aspects of PCOS.